Enzyme News and Research

RSS

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

In a recent JAMA Pediatrics study, scientists analyzed a cohort containing children and adolescents after recovering from COVID-19 to determine the dynamics of neutralizing antibodies.

2 Sep 2022

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

A recent PLoS ONE study detected neutralizing nanobodies against SARS-CoV-2 from nanobody phage display libraries and via in vitro and ex vivo high-throughput screenings.

2 Sep 2022

Inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth

Researchers at Sanford Burnham Prebys, led by Ze'ev Ronai, Ph.D., have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth.

1 Sep 2022

N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

In a new study, researchers assessed the effects of N501Y mutation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein on binding to angiotensin-converting enzyme-2 (ACE-2).

1 Sep 2022

Less is more: early short-course rapamycin effective in sustained anti-aging effects

A new study shows that a brief treatment period could have the same anti-aging efficacy and duration of effect but without the potentially serious adverse effects of chronic administration.

1 Sep 2022

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

A new review sheds light on the origins of this virus and recently acquired knowledge about its disease mechanism and the preventive and therapeutic measures appropriate in this situation.

31 Aug 2022

How effective was the Shanghai lockdown policy compared with that of other countries?

A recent study aimed to fill this gap in research by evaluating the impact of strict lockdown measures on SARS-CoV-2 Omicron transmission in Shanghai between March and April 2022.

31 Aug 2022

New treatment may be effective in addressing the long-term effects of preeclampsia

Preeclampsia is a condition that affects the placenta during pregnancy and is dangerous for both the fetus and the mother.

30 Aug 2022

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

Researchers recently assessed the infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 variant compared to preexisting variants.

30 Aug 2022

SARS-CoV-2 Omicron BA.2.75 replicates more efficiently than BA.2 or BA.5 sub-variants

In a new study, researchers characterized the clinical isolates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2.75 sub-variant.

30 Aug 2022

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

Researchers performed a structural bioinformatics analysis to evaluate the binding energy of the SARS-CoV-2 Omicron variants of concern spike protein receptor-binding domain to human angiotensin-converting enzyme 2 receptor compared to other VOCs.

30 Aug 2022

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers used culture and molecular assays to provide the first dose-response for SARS-CoV-2 solution exposed to UV222.

30 Aug 2022

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers explored the activity of an ACE2 decoy against SARS-CoV-2 Omicron variant.

30 Aug 2022

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers found proof of negative repercussions of immune history in SARS-CoV-2 infection.

30 Aug 2022

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Researchers explored the molecular and cellular mechanisms of SARS-CoV-2 infection.

30 Aug 2022

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strategy to overcome tumor-induced immunosuppression.

29 Aug 2022

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Inside a living cell, proteins and other molecules are often tightly packed together. These dense clusters can be difficult to image because the fluorescent labels used to make them visible can't wedge themselves in between the molecules.

29 Aug 2022

Study identifies two potential serological biomarkers of monkeypox infection

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

29 Aug 2022

What are the effects of e-cigarettes and their constituents on SARS-CoV-2 infection?

In a new study, researchers evaluated whether e-cigarette (EC) aerosols promoted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

29 Aug 2022

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Researchers assess the durability and effectiveness of immune responses against SARS-CoV-2 in terms of spike-binding antibody titers.

29 Aug 2022

Enzyme News and Research

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

Inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth

N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

Less is more: early short-course rapamycin effective in sustained anti-aging effects

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

How effective was the Shanghai lockdown policy compared with that of other countries?

New treatment may be effective in addressing the long-term effects of preeclampsia

What is the infectivity of SARS-CoV-2 Omicron BA.2.75 variant?

SARS-CoV-2 Omicron BA.2.75 replicates more efficiently than BA.2 or BA.5 sub-variants

The effects of amino acid substitutions on the affinity of the SARS-CoV-2 spike RBD to the human receptor hACE2

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Study reveals a novel therapeutic strategy to overcome tumor-induced immunosuppression

Microscopy technique enables visualization of unseen nanostructures within cells and tissues

Study identifies two potential serological biomarkers of monkeypox infection

What are the effects of e-cigarettes and their constituents on SARS-CoV-2 infection?

Study shows SARS-CoV-2 infection provides strong protection from reinfection

Biochemical Assays for Efficient Hit Prioritization After Screening eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo